Results 121 to 130 of about 10,900 (261)

Palivizumab prophylaxis of RSV infections in Bosnia and Herzegovina

Journal of Pediatric and Neonatal Individualized Medicine, 2016
Background: Palivizumab is indicated for respiratory syncytial virus (RSV) prophylaxis in high-risk children. Methods: Observational study, based on 4 sites in Bosnia and Herzegovina (B&H), with institutional reports of infants at high risk for RSV ...
Suada Heljic, Hajrija Maksic, Hidajeta Begic, Fahrija Skokic, Darinka Glamuzina, Tomica Bozic, Stojislav Konjevic, Veroslava Milosevic, Sabina Terzic   +8 more
doaj   +1 more source

Palivizumab and RSV prevention [PDF]

Archives of Disease in Childhood, 2000
Editor,—The letters from Drs Deshpande and Nicholl, in relation to the Impact-RSV study and the UK guidance for the use of palivizumab in the prevention of serious RSV infections, raise interesting questions that need to be addressed. I believe Dr Deshpande “has got it wrong” in that he fails to realise that the primary objective of the IMpact study ...
openaire   +1 more source

Product review on the monoclonal antibody palivizumab for prevention of respiratory syncytial virus infection

Human Vaccines & Immunotherapeutics, 2017
Respiratory syncytial virus (RSV) accounts for about 20% of all respiratory infections in children below the age of 5 y. It is associated with up to 63% of all acute respiratory infections and up to 81% of all viral lower respiratory tract infections ...
B. Resch
semanticscholar   +1 more source

Incidence and risk factors of hospitalization for bronchiolitis in preterm children: a retrospective longitudinal study in Italy

BMC Pediatrics, 2009
Background Bronchiolitis is a distressing, potentially life-threatening respiratory condition that affects infants. We evaluated the incidence and risk factors of hospitalization for broncholitis in preterm infants (i.e., a gestational age of
Mucchino Eleonora, Benincori Nicoletta, Mantovani Jessica, Pezzotti Patrizio, Di Lallo Domenico   +4 more
doaj   +1 more source

Optimal control of a fractional order epidemic model with application to human respiratory syncytial virus infection [PDF]

, 2018
A human respiratory syncytial virus surveillance system was implemented in Florida in 1999, to support clinical decision-making for prophylaxis of premature newborns. Recently, a local periodic SEIRS mathematical model was proposed in [Stat. Optim.
Rosa, Silverio, Torres, Delfim F. M.
core   +2 more sources

One‐year observational study of palivizumab prophylaxis on infants at risk for respiratory syncytial virus infection in Latin America

Jornal de Pediatria (Versão em Português), 2017
Objective: This study aims to describe real world palivizumab use and effectiveness in high‐risk Latin American infants and young children. Method: Prospective, multicenter observational study with infants at risk for severe RSV infection who received ...
Leandro Martin Castillo, Gabriela Bugarin, Juan Carlos Arias, Jairo Israel Barajas Rangel, Maria Elina Serra, Nestor Vain   +5 more
doaj   +1 more source

Prenatal tobacco smoke exposure increases hospitalizations for bronchiolitis in infants [PDF]

, 2015
BACKGROUND: Tobacco smoke exposure (TSE) is a worldwide health problem and it is considered a risk factor for pregnant women's and children's health, particularly for respiratory morbidity during the first year of life.
Adorni F, Agosti M, Aurilia C, Barberi I, Barboni G, Bertino E, Boldrini A, Bonomi A, Bottau P, Braibanti S, Carlucci A, Corona MF, Corsello G, Corso G, Coscia A, Dall’Agnola A, De Curtis M, De Luca MG, Del Vecchio A, Di Fabio S, Di Santo S, Ellero S, Fabiano A, Fabris C, Faccia P, Fanos V, Gabriele B, Gargano G, Gaudino M, Girardi E, La Forgia N, Ladetto L, Lanari M, Loprieno S, Macagno F, Magaldi R, Memo L, Molinari L, Musicco M, Natale F, Negri C, Ngalikpima CJ, Nicolini G, Nosari N, Orfeo L, Paolillo P, Parmigiani S, Piano F, Prinelli F, Puddu M, Rinaldi M, Romagnoli C, Sarnelli P, Silvestri M, Spinelli M, Umbaldo A, Vandini S, Vuerich M, Zorzi G, ” Faldella G   +59 more
core   +1 more source

Removal of the N-glycosylation sequon at position N116 located in p27 of the respiratory syncytial virus fusion protein elicits enhanced antibody responses after DNA immunization [PDF]

, 2018
Prevention of severe lower respiratory tract infections in infants caused by the human respiratory syncytial virus (hRSV) remains a major public health priority. Currently, the major focus of vaccine development relies on the RSV fusion (F) protein since
Bailey, Dalan, Boeren, Marlies, Caljon, Guy, Cos, Paul, Delputte, Peter, Leemans, Annelies, Maes, Louis, Martinet, Wim, Pintelon, Isabel, Roose, Kenny, Saelens, Xavier, Schepens, Bert, Van der Gucht, Winke   +12 more
core   +1 more source

Follow-up of the survivors of congenital diaphragmatic hernia [PDF]

, 2012
INTRODUCTION: Survivors of congenital diaphragmatic hernia have increased with the introduction of new treatment modalities and have been reported to experience ongoing medical morbidity until adulthood. AIM: To describe the long-term functional impact
Azevedo, Inês, Guimarães, Hercília, Pinto, Jorge Correia, Rocha, Gustavo   +3 more
core   +1 more source

Palivizumab for the Prophylaxis of Respiratory Syncytial Virus Disease: Expert Opinion and Recommendations for the Gulf Cooperation Council Region

Oman Medical Journal
Respiratory syncytial virus (RSV) infection poses a significant health threat to infants and young children. Considering the substantial burden in Gulf Cooperation Council (GCC) countries, prevention of RSV remains a major public health priority ...
Adel S. Alharbi, Abdul Rahman Alnemri, Ahmed Abushahin, Entesar Alhammadi, Huda Sulaiman Mohammed AlDhanhani, Laila Obaid , Mahmoud Saleh ElHalik, Mariam Kh Ayed   +7 more
doaj   +1 more source